![(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0…](https://static.cymitquimica.com/products/3D/img/QAC90820.png "Click to enlarge")
(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
CAS: 1265908-20-0
Ref. 3D-QAC90820
| 5mg | 846.00 € | ||
| 10mg | 1,273.00 € | ||
| 25mg | 2,075.00 € | ||
| 50mg | 3,320.00 € |
Product Information
- Ergosta-4,22-diene-3,6-dione, 8,14-epoxy-, (14β,22E)-
- (14β,22E)-8,14-Epoxyergosta-4,22-diene-3,6-dione
(1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione is a potent inhibitor of protein kinases that has been shown to have medicinal properties in the treatment of cancer cells and tumors. This compound inhibits the activity of several key proteins involved in the cell cycle and has been found to induce apoptosis in both Chinese hamster ovary cells and human cancer cell lines. Additionally, this compound has demonstrated anticancer activity in animal models and is excreted in urine following administration. The inhibition of protein kinases by (1S,3R,6R,7R,10R,
Chemical properties
Technical inquiry about: 3D-QAC90820 (1S,3R,6R,7R,10R,11R)-6-[(E,2R,5R)-5,6-Dimethylhept-3-en-2-yl]-7,11-dimethyl-2-oxapentacyclo[8.8.0.01,3.03,7.011,16]octadec-15-ene-1 4,17-dione
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
